Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Appl Physiol Nutr Metab. 2018 Mar 8;43(8):795–805. doi: 10.1139/apnm-2017-0858

Table 1.

Total protein abundance of Akt, AMPK, and AS160 in epitrochlearis muscles. A) For muscles incubated in No Insulin, RM ANOVA indicated a main effect of AICAR* (p<0.05) and an interaction effect (p<0.05) on Akt and a main effect of serum on AMPK and AS160 (p<0.001). Post hoc analysis revealed Akt with prior serum < No AICAR or seruma (p<0.05) and prior AICAR < No AICAR or serumb (p<0.01). AMPK with prior serum < No AICAR or seruma (p<0.01), and AS160 with prior serum < No AICAR or seruma (p<0.001) and serum+AICAR < AICAR aloned (p<0.001). For muscles incubated in Insulin, RM ANOVA indicated a main effect of serum (p<0.001) on AS160. Post hoc analysis revealed AS160 with prior serum < No AICAR or seruma (p<0.001). B) Two-way ANOVA indicated a main effect of insulin§ on total AS160. Post hoc analysis revealed AS160 with Insulin alone > No Insulini (p<0.05). Data are presented as Mean±SEM (n=10/group).

A Basal Insulin


Serum + + + +
AICAR + + Effects + + Effects
Akt 1.06±0.06 0.97±0.05a 0.91±0.04b 0.92±0.02 *,‡ 0.99±0.03 0.96±0.06 1.01±0.06 1.17±0.06
AMPK 1.12±0.06 0.93±0.05a 1.03±0.05 0.91±0.02 1.03±0.05 0.93±0.05 1.08±0.05 0.98±0.06
AS160 1.11±0.12 0.51±0.06a 1.08±0.13 0.59±0.03d 1.90±0.41 0.62±0.06a 1.33±0.14 0.85±0.10
B Basal Insulin

AICAR + + Effects
Akt 1.06±0.06 0.91±0.04 0.99±0.03 1.01±0.06
AMPK 1.12±0.06 1.03±0.05 1.03±0.05 1.08±0.05
AS160 1.11±0.12 1.08±0.13 1.90±0.41I 1.33±0.14 §